Cleared Traditional

CADIMAS VERSION 1.0 (K052023) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K052023 · Alan Penn & Associates., Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2005
Decision
135d
Days
Class 2
Risk

K052023 is an FDA 510(k) clearance for the CADIMAS VERSION 1.0. Classified as System, Nuclear Magnetic Resonance Imaging (product code LNH), Class II - Special Controls.

Submitted by Alan Penn & Associates., Inc. (Bethesda, US). The FDA issued a Cleared decision on December 8, 2005 after a review of 135 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1000 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Alan Penn & Associates., Inc. devices

Submission Details

510(k) Number K052023 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 2005
Decision Date December 08, 2005
Days to Decision 135 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
28d slower than avg
Panel avg: 107d · This submission: 135d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNH System, Nuclear Magnetic Resonance Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1000
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LNH System, Nuclear Magnetic Resonance Imaging

All 475
Devices cleared under the same product code (LNH) and FDA review panel - the closest regulatory comparables to K052023.
MAGNETOM C!
K082331 · Siemens Medical Solutions USA, Inc. · Oct 2008
MAGNETOM VERIO
K072237 · Siemens Medical Solutions USA, Inc. · Oct 2007
MAGNETOM ESSENZA
K071925 · Siemens Medical Solutions USA, Inc. · Aug 2007
GE 0.35T SIGNA OVATION WITH EXCITE MR SYSTEM
K053009 · GE Medical Systems · Nov 2005
MAGNETOM SYSTEMS WITH SOFTWARE SYNGO MR 2006A
K052164 · Siemens Medical Solutions USA, Inc. · Oct 2005
SIMTEC IM-MAXX 2 OPTION
K052315 · Siemens Medical Solutions USA, Inc. · Sep 2005